145 related articles for article (PubMed ID: 1902610)
1. Unresponsiveness of vaccinated BALB/c mice to a second inoculation of lipopolysaccharide from Brucella abortus strain 2308.
Pugh GW; Phillips M; Tabatabai LB; McDonald TJ
Vet Microbiol; 1991 Jan; 26(1-2):167-77. PubMed ID: 1902610
[TBL] [Abstract][Full Text] [Related]
2. Monophosphoryl lipid A-induced immune enhancement of Brucella abortus salt-extractable protein and lipopolysaccharide vaccines in BALB/c mice.
Tabatabai LB; Pugh GW; Stevens MG; Phillips M; McDonald TJ
Am J Vet Res; 1992 Oct; 53(10):1900-7. PubMed ID: 1456539
[TBL] [Abstract][Full Text] [Related]
3. Duration of strain 2308 infection and immunogenicity of Brucella abortus lipopolysaccharide in five strains of mice.
Phillips M; Pugh GW; Deyoe BL
Am J Vet Res; 1989 Mar; 50(3):318-22. PubMed ID: 2494912
[TBL] [Abstract][Full Text] [Related]
4. Immunologic, histopathologic, and bacteriologic responses of five strains of mice to Brucella abortus strain 2308.
Pugh GW; Zehr ES; Meador VP; Phillips M; McDonald TJ; Deyoe BL
Am J Vet Res; 1989 Mar; 50(3):323-8. PubMed ID: 2494913
[TBL] [Abstract][Full Text] [Related]
5. Increases of efficacy as vaccine against Brucella abortus infection in mice by simultaneous inoculation with avirulent smooth bvrS/bvrR and rough wbkA mutants.
Grilló MJ; Manterola L; de Miguel MJ; Muñoz PM; Blasco JM; Moriyón I; López-Goñi I
Vaccine; 2006 Apr; 24(15):2910-6. PubMed ID: 16439039
[TBL] [Abstract][Full Text] [Related]
6. Establishment of dose-response relationships in BALB/c mice, using Brucella cell surface protein and lipopolysaccharide.
Pugh GW; Tabatabai LB; Phillips M; McDonald TJ
Am J Vet Res; 1991 Feb; 52(2):261-8. PubMed ID: 1901465
[TBL] [Abstract][Full Text] [Related]
7. Immune responses and resistance to brucellosis in mice vaccinated orally with Brucella abortus RB51.
Stevens MG; Olsen SC; Palmer MV; Pugh GW
Infect Immun; 1996 Nov; 64(11):4534-41. PubMed ID: 8890203
[TBL] [Abstract][Full Text] [Related]
8. Effect of Brucella abortus transfer factor in preventing murine brucellosis.
Stevens MG; Pugh GW
FEMS Immunol Med Microbiol; 1995 Jul; 11(4):279-84. PubMed ID: 8541805
[TBL] [Abstract][Full Text] [Related]
9. Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection.
Pasquevich KA; Estein SM; García Samartino C; Zwerdling A; Coria LM; Barrionuevo P; Fossati CA; Giambartolomei GH; Cassataro J
Infect Immun; 2009 Jan; 77(1):436-45. PubMed ID: 18981242
[TBL] [Abstract][Full Text] [Related]
10. Comparison of immune responses and resistance to brucellosis in mice vaccinated with Brucella abortus 19 or RB51.
Stevens MG; Olsen SC; Pugh GW; Brees D
Infect Immun; 1995 Jan; 63(1):264-70. PubMed ID: 7806364
[TBL] [Abstract][Full Text] [Related]
11. Improved immunogenicity and protective efficacy of a divalent DNA vaccine encoding Brucella L7/L12-truncated Omp31 fusion protein by a DNA priming and protein boosting regimen.
Golshani M; Rafati S; Siadat SD; Nejati-Moheimani M; Shahcheraghi F; Arsang A; Bouzari S
Mol Immunol; 2015 Aug; 66(2):384-91. PubMed ID: 25968974
[TBL] [Abstract][Full Text] [Related]
12. Study of serum bactericidal and splenic activity of Total-OMP- CagA combination from Brucella abortus and Helicobacter pylori in BALB/c mouse model.
Abadi AH; Mahdavi M; Khaledi A; Esmaeili SA; Esmaeili D; Sahebkar A
Microb Pathog; 2018 Aug; 121():100-105. PubMed ID: 29709690
[TBL] [Abstract][Full Text] [Related]
13. Over-expression of homologous antigens in a leucine auxotroph of Brucella abortus strain RB51 protects mice against a virulent B. suis challenge.
Rajasekaran P; Surendran N; Seleem MN; Sriranganathan N; Schurig GG; Boyle SM
Vaccine; 2011 Apr; 29(17):3106-10. PubMed ID: 21376799
[TBL] [Abstract][Full Text] [Related]
14. Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant.
Al-Mariri A; Tibor A; Mertens P; De Bolle X; Michel P; Godefroid J; Walravens K; Letesson JJ
Infect Immun; 2001 Aug; 69(8):4816-22. PubMed ID: 11447155
[TBL] [Abstract][Full Text] [Related]
15. Protection of mice against Brucella abortus by immunization with polyclonal anti-idiotype antibodies.
Beauclair KD; Khansari DN
Immunobiology; 1990 Feb; 180(2-3):208-20. PubMed ID: 2111796
[TBL] [Abstract][Full Text] [Related]
16. Aerosol infection of BALB/c mice with Brucella melitensis and Brucella abortus and protective efficacy against aerosol challenge.
Kahl-McDonagh MM; Arenas-Gamboa AM; Ficht TA
Infect Immun; 2007 Oct; 75(10):4923-32. PubMed ID: 17664263
[TBL] [Abstract][Full Text] [Related]
17. Brucella abortus 2308ΔNodVΔNodW double-mutant is highly attenuated and confers protection against wild-type challenge in BALB/c mice.
Li Z; Wang S; Zhang J; Yang G; Yuan B; Huang J; Han J; Xi L; Xiao Y; Chen C; Zhang H
Microb Pathog; 2017 May; 106():30-39. PubMed ID: 28131952
[TBL] [Abstract][Full Text] [Related]
18. Protection of BALB/C mice against Brucella abortus 544 challenge by vaccination with combination of recombinant human serum albumin-l7/l12 (Brucella abortus ribosomal protein) and lipopolysaccharide.
Pakzad I; Rezaee A; Rasaee MJ; Hossieni AZ; Tabbaraee B; Kazemnejad A
Roum Arch Microbiol Immunol; 2010; 69(1):5-12. PubMed ID: 21053778
[TBL] [Abstract][Full Text] [Related]
19. Oral immunization of mice with recombinant Lactococcus lactis expressing Cu,Zn superoxide dismutase of Brucella abortus triggers protective immunity.
Sáez D; Fernández P; Rivera A; Andrews E; Oñate A
Vaccine; 2012 Feb; 30(7):1283-90. PubMed ID: 22222868
[TBL] [Abstract][Full Text] [Related]
20. Brucella abortus ΔrpoE1 confers protective immunity against wild type challenge in a mouse model of brucellosis.
Willett JW; Herrou J; Czyz DM; Cheng JX; Crosson S
Vaccine; 2016 Sep; 34(42):5073-5081. PubMed ID: 27591954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
